Pharmacological evidence for the activation of Ca2+-activated K+ channels by meloxicam in the formalin test

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 4, 2005, Pages 725-731

  Ortiz, Mario I ^a   Castañeda Hernández, Gilberto ^b   Granados Soto, Vinicio ^b  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

4 aminopyridine; Antinociception; Apamin; Charybdotoxin; Formalin test; Glibenclamide; K+ channels; Meloxicam; Tetraethylammonium; Tolbutamide

Indexed keywords

4 AMINOPYRIDINE; APAMIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHARYBDOTOXIN; FORMALDEHYDE; GLIBENCLAMIDE; MELOXICAM; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; TETRYLAMMONIUM; TOLBUTAMIDE; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; EXPERIMENTAL TEST; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT;

4-AMINOPYRIDINE; ANALGESICS, NON-NARCOTIC; ANALYSIS OF VARIANCE; ANIMALS; APAMIN; BEHAVIOR, ANIMAL; CHARYBDOTOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FORMALDEHYDE; GLYBURIDE; PAIN; PAIN MEASUREMENT; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, WISTAR; TETRAETHYLAMMONIUM; THIAZINES; THIAZOLES; TOLBUTAMIDE;

EID: 23944511880     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.05.008     Document Type: Article

References (40)

1. P. Aguirre-Bañuelos, and V. Granados-Soto Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test Eur J Pharmacol 395 2000 9 13
2. + channels activation Life Sci 74 2004 2577 2591
3. M. Ambriz-Tututi, D.A. Velázquez-Zamora, H. Urquiza-Marín, and V. Granados-Soto Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test Eur J Pharmacol 512 2005 121 127
4. + channels Science 247 1990 852 854
5. N.S. Cook, and U. Quast Potassium channel pharmacology N.S. Cook Potassium channels: structure, classification, function and therapeutic potential 1990 Ellis Horwood Limited Chichester, UK 181 255
6. + channels of muscle cells-their properties, regulation, and functions J Bioenerg Biomembr 23 1991 509 535
7. C. Domínguez-Jiménez, F. Díaz-González, I. González-Álvaro, J.M. Cesar, and F. Sánchez-Madrid Prevention of alphaII(b)beta3 activation by non-steroidal antiinflammatory drugs FEBS Lett 446 1999 318 322
8. + channels Annu Rev Pharmacol Toxicol 33 1993 597 637
9. G. Engelhardt, D. Homma, K. Schlegel, C. Schnitzler, and R. Utzmann General pharmacology of meloxicam: Part II. Effects on blood pressure, blood flow, heart rate, ECG, respiratory minute volume and interactions with paracetamol, pirenzepine, chlorthalidone, phenprocoumon and tolbutamide Gen Pharmacol 27 1996 679 688
10. R. Fleischmann, I. Iqbal, and G. Slobodin Meloxicam Expert Opin Pharmacother 3 2002 1501 1512
11. V. Granados-Soto, C.F. Argüelles, and M.I. Ortiz The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels Neuropharmacology 43 2002 917 923
12. S.K. Gupta, P. Bansal, R.K. Bhardwaj, J. Jaiswal, and T. Velpandian Comparison of analgesic and anti-inflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: pharmacokinetic parameters after topical application Skin Pharmacol Appl Skin Physiol 15 2002 105 111
13. R. Hofbauer, D. Moser, S. Kapiotis, and M. Frass Meloxicam effect on leukocyte migration under shear stress: a new perfused triple chamber (Hofbauer chamber) assay simulating an in vitro vascular wall J Investig Med 47 1999 57 65
14. A.M. Joussen, V. Poulaki, N. Mitsiades, B. Kirchhof, K. Koizumi, and S. Döhmen Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression FASEB J 16 2002 438 440
15. J.M.A. Laird, J.F. Herrero, P. Garcia de la Rubia, and F. Cervero Analgesic activity of the novel COX-2 preferring NSAID, meloxicam in mono-arthritic rats: central and peripheral components Inflamm Res 46 1997 203 210
16. + channel pathway in the antinociceptive action of ketorolac Eur J Pharmacol 426 2001 41 46
17. J.A. López-García, and J.M. Laird Central antinociceptive effects of meloxicam on rat spinal cord in vitro Neuroreport 9 1998 647 651
18. A.B. Malmberg, and T.L. Yaksh Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat J Pharmacol Exp Ther 263 1992 136 146
19. A. Mathie, J.R.A. Wooltorton, and C.S. Watkins Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents Gen Pharmacol 30 1998 13 24
20. S. Noble, and J.A. Balfour Meloxicam Drugs 51 1996 424 430
21. K. Ogino, K. Hatanaka, M. Kawamura, M. Katori, and Y. Harada Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1 Pharmacology 55 1997 44 53
22. K. Ogino, K. Saito, T. Osugi, and H. Satoh Meloxicam (Mobic): a review of its pharmacological and clinical profile Nippon Yakurigaku Zasshi 120 2002 391 397
23. + channels by diclofenac Eur J Pharmacol 438 2002 85 91
24. M.I. Ortiz, V. Granados-Soto, and G. Castañeda-Hernández The NO-cGMP-K(+) channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin Pharmacol Biochem Behav 76 2003 187 195
25. M.I. Ortiz, G. Castañeda-Hernández, and V. Granados-Soto Possible involvement of potassium channels in peripheral antinociception induced by metamizol: lack of participation of ATP-sensitive K+ channels Pharmacol Biochem Behav 74 2003 465 470
26. M. Pairet, J. van Ryn, H. Schierok, A. Mauz, G. Trummlitz, and G. Engelhardt Differential inhibition of cyclooxygenase-1 and-2 by meloxicam and its 4′-isomer Inflamm Res 47 1998 270 276
27. G. Pinardi, F. Sierralta, and H.F. Miranda Atropine reverses the antinociception of nonsteroidal anti-inflammatory drugs in the tail-flick test of mice Pharmacol Biochem Behav 74 2003 603 608
28. + channels Br J Pharmacol 129 2000 110 114
29. + channels J Physiol Paris 79 1984 259 264
30. B. Rosati, M. Rochetti, A. Zaza, and E. Wanke Sulfonylureas blockade of neural and cardiac HERG channels FEBS Lett 440 1998 125 130
31. N.E. Saade, H.F. Lawand, B. Safieh-Garabedian, S.A. Kanaan, S.F. Atweh, and S.J. Jabbur Thymulin induces c-fos expression in the spinal cord of rats which is reversed by meloxicam and morphine J Neuroimmunol 97 1999 16 24
32. A.R. Santos, E.M. Vedana, and G.A. De Freitas Antinociceptive effect of meloxicam, in neurogenic and inflammatory nociceptive models in mice Inflamm Res 47 1998 302 307
33. 2-induced hyperalgesic paw Br J Pharmacol 134 2001 127 131
34. + channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside Eur J Pharmacol 400 2000 67 71
35. D. Stretton, M. Miura, M.G. Bevisi, and P.J. Barnes Calcium-activated potassium channels mediate prejunctional inhibition of peripheral sensory nerves Proc Natl Acad Sci U S A 9 1992 1325 1329
36. R.J. Tallarida, and R.B. Murray Manual of pharmacologic calculations with computer programs 1981 Springer-Verlag New York
37. S.P. Welch, and L.D. Dunlow Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists, a common mechanism of action? J Pharmacol Exp Ther 267 1993 390 399
38. H. Wheeler-Aceto, and A. Cowan Standardization of the rat paw formalin test for the evaluation of analgesics Psychopharmacology 104 1991 35 44
39. M. Zimmermann Ethical guidelines for investigations on experimental pain in conscious animals Pain 16 1983 109 110
40. M. Zimmermann Basic concepts of pain and pain therapy Arzneimittelforschung 34 1984 1053 1059